首页 | 本学科首页   官方微博 | 高级检索  
     

载药释放系统治疗骨髓炎合并骨缺损研究进展
引用本文:刘琛,阳青松,苏佳灿. 载药释放系统治疗骨髓炎合并骨缺损研究进展[J]. 组织工程与重建外科, 2012, 8(2): 117-120. DOI: 10.3969/j.issn.1673-0364.2012.02.016
作者姓名:刘琛  阳青松  苏佳灿
作者单位:第二军医大学附属长海医院骨科;第二军医大学
基金项目:上海市人事局人才发展基金(2009003);上海市卫生系统新优青计划(2011032)
摘    要:
自1970年发明了第一个人工骨替代品-PMMA,研究人员进行了大量的临床研究。现如今,PMMA已经广泛应用于临床治疗骨髓炎。临床治疗结果及研究结果表明,PMMA在治疗骨髓炎和降低病死率上起了很大的作用。根据材料的降解性质,载药系统常常可以分为生物降解性材料和不可降解性材料。两种载药系统作为人工骨材料都需要在药物释放上达到局部最小抑菌浓度。本文将就载药系统类型、制作方法、载药系统性质、药物释放动力学进行综述。

关 键 词:载药系统  骨髓炎  骨缺损  抗生素  生长因子  

Advancement of Drug-Delivery System in the Treatment of Osteomyelitis with Bone Defects
LIU Chen,Yang Qingsong,SU Jiacan. Advancement of Drug-Delivery System in the Treatment of Osteomyelitis with Bone Defects[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2012, 8(2): 117-120. DOI: 10.3969/j.issn.1673-0364.2012.02.016
Authors:LIU Chen  Yang Qingsong  SU Jiacan
Affiliation:1 The Second Military Medical University,Shanghai 200433,China;2 Changhai Hospital,The Second Military Medical University,Shanghai 200433,China.
Abstract:
In 1970,the first bone substitute-PMMA was created and a lot of clinical studies were conducted.Clinical applications demonstrate good results and the mortality rate of osteomyelitis is significantly reduced.According to the degradation of materials,the drug-delivery system can be divided into biodegradable materials and non-degradable materials.As the bone substitute,the two types of materials were required to achieve the minimum inhibitory concentration in nature.The system types,preparation methods,the nature of the drug,and the drug release kinetics were reviewed.
Keywords:Drug-delivery system  Osteomyelitis  Bone defects  Antibiotic  Growth factor
本文献已被 CNKI 等数据库收录!
点击此处可从《组织工程与重建外科》浏览原始摘要信息
点击此处可从《组织工程与重建外科》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号